ID   KNBCCS6 E6/E7
AC   CVCL_IU65
DR   Wikidata; Q54900247
RX   Patent=US20190242874;
CC   Group: Patented cell line.
CC   Sequence variation: Mutation; HGNC; 9585; PTCH1; Simple; p.Pro643Thrfs*11 (c.1925insC) (H652X); Zygosity=Heterozygous (from parent cell line).
CC   Transfected with: UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Transfected with: UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C2892; Nevoid basal cell carcinoma syndrome
DI   ORDO; Orphanet_377; Gorlin syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IU64 ! KNBCCS6
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 05-10-23; Version: 12
//
RX   Patent=US20190242874;
RA   Burty E., Magnaldo T., Gache Y., Aubert J.;
RT   "Human epithelial cell line for 3-D modelizing of cancer and treatment
RT   thereof.";
RL   Patent number US20190242874, 08-Aug-2019.
//